ERBB2 and breast cancer: In order to confirm the functional roles of TFF3 in acquired trastuzumab resistance in HER2+/ER+ breast cancer cells, we depleted endogenous TFF3 in trastuzumab resistant BT474 cells with siRNA against TFF3.